ACAMPROSATE (CAMPRAL)

Similar documents
Drug Name Tier Drug Name Tier

2010 Drugs Requiring Prior Authorization

List of Designated High-Cost Drugs

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

MDwise Self-Administered Codes for Medical

2016 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Prior Authorization Requirements

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Ally Rx D-SNP Current as of r 1, 2017

Products Affected ACTEMRA SUBCUTANEOUS ACTEMRA INTRAVENOUS SOLUTION 400 MG/20 ML (20 MG/ML), 80 MG/4 ML (20 MG/ML)

RIVERSPRING STAR ISNP PRIOR AUTHORIZATION

Specialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.

2014 Quantity Limits (QL) Criteria

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Thank you for your request for information that has been processed under reference number

BELEODAQ. Prior Authorization Criteria Memorial Hermann Advantage HMO & PPO Formulary ID: Version 10 Effective Date: 6/1/2015

Aetna Better Health of Illinois Medicaid Formulary Updates

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

acromegaly Drugs Covered Uses Exclusion Criteria Required Medical Information Age Restriction Prescriber Restriction Coverage Duration

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Advantage by Peach State Health Plan 2012 Prior Authorization Listing. Approved 10/23/2011 Effective October 2011

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Plan Year 2017 Prior Authorization (PA) Criteria

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Plan Year 2019 Prior Authorization (PA) Criteria

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

2018 Prior Authorization Requirements

Plan Year 2018 Prior Authorization (PA) Criteria

BELEODAQ. Prior Authorization Criteria Memorial Hermann HMO Formulary ID: Version 19 Effective Date: 10/27/2015. PRODUCT(s) AFFECTED BELEODAQ

Step Therapy Criteria

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

MEDICATION(S) ORENCIA 125 MG/ML SYRINGE, ORENCIA 50 MG/0.4 ML SYRINGE, ORENCIA 87.5 MG/0.7 ML SYRINGE, ORENCIA CLICKJECT

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

March 2018 P & T Updates

COVERED USES All medically accepted indications not otherwise excluded from Part D

ARANESP ALBUMIN FREE ARANESP ALBUMIN FREE SURE ARICEPT ARICEPT ODT EXELON

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Prescription benefit updates Large group

Prescription Drug Benefit Rider V

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

Medicare Part B Covered Medications

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

Ultimate Health Plans (HMO)

EXCLUSION CRITERIA Active infection, live vaccines, concomitant use with biological Disease Modifying Anti-Rheumatic Drugs (DMARDs).

Aetna Better Health. Specialty Drug Program

Injectable Drugs Requiring Pre-Service Approval

Prior Authorization Group AVITA CREAM, AVITA GEL, RETIN-A MICR GEL, TRETINOIN CREAM, TRETINOIN GEL

Health Partners Medicare Prime 2019 Formulary Changes

Prescription Drug Benefit Rider

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

ACTIQ (FENTANYL LOZENGE)

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure-Xtra Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria

BENEFIT CHANGES TO NBPDP

Step Therapy Requirements. Effective: 11/01/2018

March 2017 Pharmacy & Therapeutics Committee Decisions

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

PAWEB_File_AAH_12140_A2TC

2014 AlohaCare Advantage (HMO) and AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Prior Authorization Requirements

TRICARE Uniform Formulary. Pre-Authorization Requirements

Post-operative pain following CABG surgery Allergic-type reaction to aspirin, NSAIDs, or sulfonamides

Cimzia. Cimzia (certolizumab pegol) Description

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Xeljanz. Xeljanz, Xeljanz XR (tofacitinib) Description

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

Medi-Cal Code 1 Drug List

EXCLUSION CRITERIA Active infection, live vaccines, concomitant use with biological Disease Modifying Anti-Rheumatic Drugs (DMARDs).

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

PPHP 2017 Formulary 2017 Step Therapy Criteria

Lista de medicamentos especializados

2013 Prior Authorization (PA) Criteria

Drug Formulary. A healthier you. A healthier community.

FirstCarolinaCare Insurance Company. Step Therapy Requirements

ANTICONVULSANTS. Details

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009

ANTICONVULSANTS. Details

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Geisinger Health Plan Prior Authorization Requirements

Quarterly pharmacy formulary change notice

Transcription:

ACAMPROSATE (CAMPRAL) ACAMPROSATE CALCIUM Creatinine clearance less than 30 PAGE 1 LAST UPDATED 06/2016

ADALIMUMAB (HUMIRA) HUMIRA, HUMIRA PEDIATRIC CROHN'S, HUMIRA PEN, HUMIRA PEN CROHN'S-UC-HS, HUMIRA PEN PSORIASIS must have inadequate response to at least one disease-modifying anti-rheumatic drug None PAGE 2 LAST UPDATED 06/2016

AMBRISENTAN (LETAIRIS) LETAIRIS Pregnancy enrollment in LEAP Program PAGE 3 LAST UPDATED 06/2016

APIXABAN (ELIQUIS) ELIQUIS PAGE 4 LAST UPDATED 06/2016

APOMORPHINE (APOKYN) APOKYN PAGE 5 LAST UPDATED 06/2016

APREMILAST (OTEZLA) OTEZLA PAGE 6 LAST UPDATED 06/2016

APREPITANT (EMEND) EMEND 125 MG CAPSULE, EMEND 40 MG CAPSULE, EMEND 80 MG CAPSULE, EMEND TRIPACK 3 months None PAGE 7 LAST UPDATED 06/2016

CINACALCET (SENSIPAR) SENSIPAR PAGE 8 LAST UPDATED 06/2016

CLOPIDOGREL (PLAVIX) CLOPIDOGREL 75 MG TABLET PAGE 9 LAST UPDATED 06/2016

DABIGATRAN (PRADAXA) PRADAXA. Beneficiary has tried and failed warfarin therapy PAGE 10 LAST UPDATED 06/2016

DALFAMPRIDINE (AMPYRA) AMPYRA PAGE 11 LAST UPDATED 06/2016

DAPTOMYCIN (CUBICIN) CUBICIN 2 weeks PAGE 12 LAST UPDATED 06/2016

DENOSUMAB (PROLIA) PROLIA PAGE 13 LAST UPDATED 06/2016

DESVENLAFAXINE SUCCINATE (PRISTIQ) DESVENLAFAXINE ER PAGE 14 LAST UPDATED 06/2016

DEXTROMETHORPHAN/QUINIDINE (NUEDEXTA) NUEDEXTA Amyotrophic Lateral Sclerosis and Multiple Sclerosis PAGE 15 LAST UPDATED 06/2016

DICLOFENAC (SOLARAZE) DICLOFENAC SODIUM 3% GEL PAGE 16 LAST UPDATED 06/2016

DICLOFENAC EPOLAMINE (FLECTOR) FLECTOR 2 weeks PAGE 17 LAST UPDATED 06/2016

DIMETHYL FUMARATE (TECFIDERA) TECFIDERA PAGE 18 LAST UPDATED 06/2016

DORNASE ALFA (PULMOZYME) PULMOZYME PAGE 19 LAST UPDATED 06/2016

DROXIDOPA (NORTHERA) NORTHERA PAGE 20 LAST UPDATED 06/2016

DULAGLUTIDE (TRULICITY) TRULICITY PAGE 21 LAST UPDATED 06/2016

ELTROMBOPAG (PROMACTA) PROMACTA PAGE 22 LAST UPDATED 06/2016

EMPAGLIFLOZIN (JARDIANCE) JARDIANCE Currently on other anti-diabetic agents. PAGE 23 LAST UPDATED 06/2016

ENOXAPARIN (LOVENOX) ENOXAPARIN SODIUM reduce frequency with creatinine clearance less than 30 Minimum of 5 days of therapy and may extend up to 35 days unless prescribed for a shorter duration None PAGE 24 LAST UPDATED 06/2016

EPOETIN (EPOGEN) EPOGEN 10,000 UNITS/ML VIAL, EPOGEN 2,000 UNITS/ML VIAL, EPOGEN 20,000 UNITS/2 ML VIAL, EPOGEN 20,000 UNITS/ML VIAL, EPOGEN 3,000 UNITS/ML VIAL, EPOGEN 4,000 UNITS/ML VIAL to be continued only if hemoglobin is 12 or less 6 months PAGE 25 LAST UPDATED 06/2016

EPOETIN (PROCRIT) PROCRIT bleeding, autoimmune hemolytic anemia, inufficient vitamin stores, uncontrolled HTN, cancer patients with radiation alone to be continued only if hemoglobin is 12 or less 6 months PAGE 26 LAST UPDATED 06/2016

EVEROLIMUS (ZORTRESS) ZORTRESS PAGE 27 LAST UPDATED 06/2016

FENTANYL LOZENGE FENTANYL CIT OTFC 1,200 MCG, FENTANYL CIT OTFC 1,600 MCG, FENTANYL CITRATE OTFC 200 MCG, FENTANYL CITRATE OTFC 400 MCG, FENTANYL CITRATE OTFC 600 MCG, FENTANYL CITRATE OTFC 800 MCG Opiod tolerant PAGE 28 LAST UPDATED 06/2016

FENTANYL TRANSDERMAL PATCH FENTANYL 100 MCG/HR PATCH, FENTANYL 12 MCG/HR PATCH, FENTANYL 25 MCG/HR PATCH, FENTANYL 50 MCG/HR PATCH, FENTANYL 75 MCG/HR PATCH Refractory or intolerant to oral pain management PAGE 29 LAST UPDATED 06/2016

FIDAXOMICIN (DIFICID) DIFICID 10 days PAGE 30 LAST UPDATED 06/2016

FILGRASTIM (NEUPOGEN) NEUPOGEN, ZARXIO not for afebrile neutropenia 6 months None PAGE 31 LAST UPDATED 06/2016

GOLIMUMAB (SIMPONI) SIMPONI, SIMPONI ARIA PAGE 32 LAST UPDATED 06/2016

IMIQUIMOD (ALDARA) IMIQUIMOD 5% CREAM PACKET 4 months PAGE 33 LAST UPDATED 06/2016

INFLIXIMAB (REMICADE) REMICADE None PAGE 34 LAST UPDATED 06/2016

INTERFERON BETA 1A (REBIF, AVONEX) AVONEX, AVONEX ADMINISTRATION PACK, AVONEX PEN, REBIF, REBIF REBIDOSE Neurologist 3 months PAGE 35 LAST UPDATED 06/2016

IVACAFTOR (KALYDECO) KALYDECO PAGE 36 LAST UPDATED 06/2016

LEDIPASVIR/SOFOSBUVIR (HARVONI) HARVONI 12 weeks in patients without cirrhosis, 24 weeks in patients with cirrhosis PAGE 37 LAST UPDATED 06/2016

LENALIDOMIDE (REVLIMID) REVLIMID 3 months PAGE 38 LAST UPDATED 06/2016

LEVOMILNACIPRAN (FETZIMA) FETZIMA PAGE 39 LAST UPDATED 06/2016

LINEZOLID (ZYVOX) LINEZOLID, LINEZOLID-0.9% NACL low tyramine diet 28 days PAGE 40 LAST UPDATED 06/2016

LOMITAPIDE MESYLATE (JUXTAPID) JUXTAPID PAGE 41 LAST UPDATED 06/2016

LUBIPROSTONE (AMITIZA) AMITIZA PAGE 42 LAST UPDATED 06/2016

MACITENTAN (OPSUMIT) OPSUMIT PAGE 43 LAST UPDATED 06/2016

MEGESTROL MEGESTROL ACET 40 MG/ML SUSP, MEGESTROL ACET 400 MG/10 ML Assess for weight gain after initial coverage duration 6 months PAGE 44 LAST UPDATED 06/2016

METHYLNALTREXONE (RELISTOR) RELISTOR PAGE 45 LAST UPDATED 06/2016

MIPOMERSEN SODIUM (KYNAMRO) KYNAMRO PAGE 46 LAST UPDATED 06/2016

MODAFANIL (PROVIGIL) MODAFINIL None PAGE 47 LAST UPDATED 06/2016

NINTEDANIB ESYLATE (OFEV) OFEV PAGE 48 LAST UPDATED 06/2016

PARATHYROID HORMONE (NATPARA) NATPARA PAGE 49 LAST UPDATED 06/2016

PART D VS PART B ACETYLCYSTEINE 10% VIAL, ACETYLCYSTEINE 20% VIAL, ALBUTEROL 2.5 MG/0.5 ML SOL, ALBUTEROL 5 MG/ML SOLUTION, ALBUTEROL SUL 0.63 MG/3 ML SOL, ALBUTEROL SUL 1.25 MG/3 ML SOL, ALBUTEROL SUL 2.5 MG/3 ML SOLN, AMINOSYN II, AMINOSYN II WITH ELECTROLYTES, AMINOSYN M, AMINOSYN WITH ELECTROLYTES, AMINOSYN-HBC, AMINOSYN-PF, AMINOSYN-RF, AZATHIOPRINE 50 MG TABLET, AZATHIOPRINE SODIUM, BUDESONIDE 0.25 MG/2 ML SUSP, BUDESONIDE 0.5 MG/2 ML SUSP, BUDESONIDE 1 MG/2 ML INH SUSP, CARIMUNE NF NANOFILTERED, CELLCEPT 500 MG VIAL, CLINIMIX, CLINIMIX E 4.25%-10% SOLUTION, CLINISOL, CROMOLYN 20 MG/2 ML NEB SOLN, CYCLOPHOSPHAMIDE 25 MG CAPSULE, CYCLOPHOSPHAMIDE 50 MG CAPSULE, CYCLOSPORINE 100 MG CAPSULE, CYCLOSPORINE 100 MG/ML SOLN, CYCLOSPORINE 25 MG CAPSULE, CYCLOSPORINE 50 MG/ML AMPUL, CYCLOSPORINE 50 MG/ML VIAL, CYCLOSPORINE MODIFIED, ELIGARD, ENGERIX-B ADULT, ENGERIX-B PEDIATRIC-ADOLESCENT, ETOPOSIDE 1,000 MG/50 ML VIAL, ETOPOSIDE 100 MG/5 ML VIAL, ETOPOSIDE 500 MG/25 ML VIAL, GAMMAGARD LIQUID, GAMMAGARD S-D, GAMMAPLEX, GAMUNEX, GAMUNEX-C, GENGRAF, HEPARIN 10,000 UNIT/10 ML VIAL, HEPARIN 30,000 UNIT/30 ML VIAL, HEPARIN 40,000 UNITS/4 ML VIAL, HEPARIN 50,000 UNITS/5 ML VIAL, HEPARIN SOD 1,000 UNIT/ML VIAL, HEPARIN SOD 10,000 UNIT/ML VL, HEPATAMINE, INTRALIPID, IPRATROPIUM BR 0.02% SOLN, IPRATROPIUM- ALBUTEROL, LEVALBUTEROL CONCENTRATE, LEVALBUTEROL 0.31 MG/3 ML SOL, LEVALBUTEROL 0.63 MG/3 ML SOL, LEVALBUTEROL 1.25 MG/3 ML SOL, LUPRON DEPOT, LUPRON DEPOT-PED, METHOTREXATE 1 GM VIAL, METHOTREXATE 100 MG/4 ML VIAL, METHOTREXATE 2.5 MG TABLET, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, NEBUPENT, NULOJIX, NUTRILIPID, ONDANSETRON 4 MG/5 ML SOLUTION, ONDANSETRON HCL 24 MG TABLET, ONDANSETRON HCL 4 MG TABLET, ONDANSETRON HCL 8 MG TABLET, ONDANSETRON ODT, PREMASOL, PRIVIGEN, PROCALAMINE, PROGRAF 5 MG/ML AMPULE, PROLEUKIN, PROSOL, RECOMBIVAX HB 10 MCG/ML VIAL, RECOMBIVAX HB 40 MCG/ML VIAL, RECOMBIVAX HB 5 MCG/0.5 ML VL, SULFAMETHOXAZOLE-TMP INJ VIAL, TOBRAMYCIN 300 MG/5 ML AMPULE, TRAVASOL, TROPHAMINE, VANCOMYCIN 1 GM ADD-VAN VIAL, VANCOMYCIN 1 GM VIAL, VANCOMYCIN 500 MG A-V VIAL, VANCOMYCIN 500 MG VIAL, VANCOMYCIN HCL 10 GM VIAL, VANCOMYCIN HCL 5 GM VIAL, VANCOMYCIN HCL 750 MG VIAL DETAILS This drug may be covered under Medicare Part B or D depending on the circumstances. Information may need to be submitted describing the use and setting of the drug to make the determination. PAGE 50 LAST UPDATED 06/2016

PLERIXAFOR (MOZOBIL) MOZOBIL 4 days PAGE 51 LAST UPDATED 06/2016

POMALIDOMIDE (POMALYST) POMALYST 3 months PAGE 52 LAST UPDATED 06/2016

PREGABALIN (LYRICA) LYRICA PAGE 53 LAST UPDATED 06/2016

QUININE SULFATE QUININE SULFATE 324 MG CAPSULE 1 week PAGE 54 LAST UPDATED 06/2016

RIBAVIRIN ORAL REBETOL 40 MG/ML SOLUTION, RIBAVIRIN 3 months PAGE 55 LAST UPDATED 06/2016

RIFAXIMIN (XIFAXAN) XIFAXAN 200 MG TABLET 3 days PAGE 56 LAST UPDATED 06/2016

RIOCIGUAT (ADEMPAS) ADEMPAS PAGE 57 LAST UPDATED 06/2016

ROFLUMILAST (DALIRESP) DALIRESP PAGE 58 LAST UPDATED 06/2016

ROTIGOTINE (NEUPRO) NEUPRO PAGE 59 LAST UPDATED 06/2016

SARGRAMOSTIM (LEUKINE) LEUKINE 250 MCG VIAL 2 months PAGE 60 LAST UPDATED 06/2016

SELEGILENE TRANSDERMAL EMSAM PAGE 61 LAST UPDATED 06/2016

SILDENAFIL CITRATE (REVATIO) SILDENAFIL PAGE 62 LAST UPDATED 06/2016

SIMEPREVIR (OLYSIO) OLYSIO 12 or 24 weeks Duration depends on past medical history, cirrhosis history, and genotype PAGE 63 LAST UPDATED 06/2016

SIROLIMUS (RAPAMUNE) RAPAMUNE 1 MG/ML ORAL SOLN, SIROLIMUS 0.5 MG TABLET, SIROLIMUS 1 MG TABLET, SIROLIMUS 2 MG TABLET PAGE 64 LAST UPDATED 06/2016

SOFOSBUVIR (SOLVALDI) SOVALDI 12, 16, 24 or 48 weeks Consider genotype, cirrhosis status, previous failure of PEG-IFN/RBV/protease inhibitors/sofosbuvir, HCV in an allograft, decompensated cirrhosis, if awaiting transplant and concurrent treatment PAGE 65 LAST UPDATED 06/2016

SOMATROPIN GENOTROPIN, HUMATROPE, NORDITROPIN FLEXPRO, NORDITROPIN NORDIFLEX, NUTROPIN AQ, NUTROPIN AQ NUSPIN, OMNITROPE, SAIZEN, SEROSTIM, ZORBTIVE PAGE 66 LAST UPDATED 06/2016

TACROLIMUS (PROGRAF) ASTAGRAF XL, ENVARSUS XR, TACROLIMUS 0.5 MG CAPSULE, TACROLIMUS 1 MG CAPSULE, TACROLIMUS 5 MG CAPSULE PAGE 67 LAST UPDATED 06/2016

TADALAFIL (ADCIRCA) ADCIRCA PAGE 68 LAST UPDATED 06/2016

TASIMELTEON (HETLIOZ) HETLIOZ PAGE 69 LAST UPDATED 06/2016

TEDIZOLID PHOSPHATE (SIVEXTRO) SIVEXTRO 6 days PAGE 70 LAST UPDATED 06/2016

TERIFLUNOMIDE (AUBAGIO) AUBAGIO 1 year PAGE 71 LAST UPDATED 06/2016

TERIPARATIDE (FORTEO) FORTEO 2 years None PAGE 72 LAST UPDATED 06/2016

TETRAHYDROCANNABINOL DRONABINOL PAGE 73 LAST UPDATED 06/2016

TICAGRELOR (BRILINTA) BRILINTA PAGE 74 LAST UPDATED 06/2016

TIGECYCLINE (TYGACIL) TYGACIL 14 days PAGE 75 LAST UPDATED 06/2016

TOFACITINIB CITRATE (XELJANZ) XELJANZ, XELJANZ XR PAGE 76 LAST UPDATED 06/2016

TREPROSTINIL (REMODULIN) REMODULIN PAGE 77 LAST UPDATED 06/2016

VANCOMYCIN ORAL SOLUTION VANCOMYCIN HCL 125 MG CAPSULE, VANCOMYCIN HCL 250 MG CAPSULE 2 weeks None PAGE 78 LAST UPDATED 06/2016

VARENICLINE (CHANTIX) CHANTIX 0.5 MG TABLET, CHANTIX 1 MG CONT MONTH BOX, CHANTIX 1 MG TABLET, CHANTIX STARTING MONTH BOX 12 weeks None PAGE 79 LAST UPDATED 06/2016

VILAZODONE (VIIBRYD) VIIBRYD 10 MG TABLET, VIIBRYD 10-20 MG STARTER PACK, VIIBRYD 20 MG TABLET, VIIBRYD 40 MG TABLET PAGE 80 LAST UPDATED 06/2016

VORTIOXETINE (BRINTELLIX) BRINTELLIX PAGE 81 LAST UPDATED 06/2016

PAGE 82 LAST UPDATED 06/2016